Reuters: Lung disease treatment carries heart risks

[NaDiNe]

Lung disease treatment carries heart risks
      

NEW YORK (Reuters Health) - The long-term use of inhaled drugs, referred to as "anticholinergic," such as ipratropium and tiotropium, for chronic obstructive pulmonary disease may increase the risk of heart attack, stroke and death, the results of a review study suggest.
<p>You are not allowed to view links. Register or Login</p><div class="feedflare">
You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login
</div><img src="You are not allowed to view links. Register or Login" height="1" width="1"/>
      

You are not allowed to view links. Register or Login